Related Experiment Videos
[Leukemic immunophenotyping with flow cytometry]
1Department of Pediatrics, Faculty of Medicine, Tokyo Medical and Dental University.
Insights
Flow cytometry immunophenotyping of leukemic cells shows promise for classification but faces challenges. Integrating morphology and improved marker nomenclature is key for accurate leukemia diagnosis and treatment.
Area of Science:
- Hematology
- Immunology
- Biotechnology
Context:
- Flow cytometry is crucial for immunophenotyping leukemic cells.
- Accurate leukemia classification relies on robust diagnostic methods.
Purpose:
- To evaluate the clinical efficacy of flow cytometric immunophenotyping for leukemia.
- To identify challenges in surface and intracellular immunophenotyping of leukemic cells.
Summary:
- Multi-parametric analysis suggests flow cytometry can independently classify leukemia.
- Complementary relationships exist between morphological and phenotypic approaches.
- Defective cell morphology and complex marker expression (mixed leukemia, partial expression) complicate interpretations.
Impact:
- Highlights the need for integrating morphological and phenotypic data for improved leukemia diagnosis.
- Suggests enhancing the CD nomenclature system for better marker standardization.
- Aims to improve the quality and performance of leukemic phenotyping.
Abstract:
We have evaluated the clinical efficacy and problematic items of flow cytometric surface and intracellular immunophenotyping of leukemic cells. The multi-parametric analysis on the results of leukemic phenotyping displayed a possibility of an independent phenotypical classification, but concurrently we recognized complementary relationships between the morphological and phenotypic approaches. Defective information on the morphology of leukemic cells unexpectedly introduced an insufficient quality in performance of leukemic phenotyping. On the other hand, the interpretations of phenotypic outcomes were complicated in cases with mixed leukemia and partial expression of a marker. Finally we hope further integration of the expression spectrum of markers, including the improvement of CD nomenclature system.